Research
Hormonal
GLP-1 receptor agonists (GLP-1RA) are effective pharmacological interventions for obesity that work by binding to GLP-1 receptors to stimulate insulin secretion, suppress glucagon, delay gastric emptying, and reduce appetite.
GLP-1 receptor agonists are a key pharmacological tool for treating obesity. They work by mimicking a gut hormone to reduce appetite and improve metabolic function. Consult a doctor to see if this treatment is appropriate for you.
StrongSupportsHIGH confidence
GLP-1 is a peptide hormone... It binds to the GLP-1 receptor... Upon receptor activation, GLP-1 stimulates insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite.
Why this rating
Review of established pharmacological mechanisms.
Source
The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies
Gašper Tonin et al. · Obesity Reviews · 2025
narrative_reviewCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →